Sanofi warning on antidepressant Norpramin | Reuters

Links shared publicly online about this topic.

1,559
total visits

Sanofi warning on antidepressant Norpramin | Reuters

WASHINGTON (Reuters) - French drugmaker Sanofi-Aventis SA has warned that its antidepressant Norpramin should be given with extreme caution to patients with a history of certain heart problems, the U.S.

View full resource at feeds.reuters.com

Tags: Heart, Antidepressant, Norpramin, Sanofi-Aventis

Most Recently Shared on December 2, 2009 at 8:51 pm By:

Reuters Health

Sanofi warning on antidepressant Norpramin http://link.reuters.com/peq64g

2 years ago...

Retweet

Favorite

Symposier - New Warnings on Norpramin (February 2010)

symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru Sanofi-Aventis is notifying healthcare professionals about updated safety information for the antidepressant Norpramin (desipramine hydrochloride). The section on overdosage now notes that overdoses of this drug have resulted in a higher death rate than overdoses of other tricyclic antidepressants. Also, a new warning in the labeling now says to use extreme caution when giving this drug to patients with a family history of sudden death, cardiac dysr” View full resource at symposier.com